ChemoMetec A/S (LON:0DZ0)

ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of GBP 825.15 million. The enterprise value is 793.76 million.

Market Cap	825.15M
Enterprise Value	793.76M

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Oct 10, 2025

Share Statistics

Current Share Class	17.40M
Shares Outstanding	n/a
Shares Change (YoY)	+0.07%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	3.75%
Owned by Institutions (%)	34.38%
Float	16.75M

Valuation Ratios

The trailing PE ratio is 39.90 and the forward PE ratio is 28.51.

PE Ratio	39.90
Forward PE	28.51
PS Ratio	14.33
PB Ratio	10.82
P/TBV Ratio	14.58
P/FCF Ratio	39.41
P/OCF Ratio	33.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.91, with an EV/FCF ratio of 37.91.

EV / Earnings	38.39
EV / Sales	13.82
EV / EBITDA	27.91
EV / EBIT	29.49
EV / FCF	37.91

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.01.

Current Ratio	3.93
Quick Ratio	3.02
Debt / Equity	0.01
Debt / EBITDA	0.02
Debt / FCF	0.03
Interest Coverage	172.83

Financial Efficiency

Return on equity (ROE) is 28.31% and return on invested capital (ROIC) is 46.70%.

Return on Equity (ROE)	28.31%
Return on Assets (ROA)	19.08%
Return on Invested Capital (ROIC)	46.70%
Return on Capital Employed (ROCE)	35.01%
Weighted Average Cost of Capital (WACC)	12.33%
Revenue Per Employee	334,882
Profits Per Employee	120,222
Employee Count	170
Asset Turnover	0.65
Inventory Turnover	0.18

Taxes

In the past 12 months, ChemoMetec has paid 6.03 million in taxes.

Income Tax	6.03M
Effective Tax Rate	22.58%

Stock Price Statistics

The stock price has decreased by -23.52% in the last 52 weeks. The beta is 1.47, so ChemoMetec's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	-23.52%
50-Day Moving Average	681.54
200-Day Moving Average	604.73
Relative Strength Index (RSI)	11.05
Average Volume (20 Days)	5,413

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of GBP 57.60 million and earned 20.68 million in profits. Earnings per share was 1.19.

Revenue	57.60M
Gross Profit	55.03M
Operating Income	26.99M
Pretax Income	26.71M
Net Income	20.68M
EBITDA	28.52M
EBIT	26.99M
Earnings Per Share (EPS)	1.19

Balance Sheet

The company has 32.08 million in cash and 608,685 in debt, with a net cash position of 31.47 million.

Cash & Cash Equivalents	32.08M
Total Debt	608,685
Net Cash	31.47M
Net Cash Per Share	n/a
Equity (Book Value)	76.23M
Book Value Per Share	4.38
Working Capital	42.19M

Cash Flow

In the last 12 months, operating cash flow was 24.54 million and capital expenditures -3.60 million, giving a free cash flow of 20.94 million.

Operating Cash Flow	24.54M
Capital Expenditures	-3.60M
Free Cash Flow	20.94M
FCF Per Share	n/a

Margins

Gross margin is 95.54%, with operating and profit margins of 46.86% and 35.90%.

Gross Margin	95.54%
Operating Margin	46.86%
Pretax Margin	46.37%
Profit Margin	35.90%
EBITDA Margin	49.51%
EBIT Margin	46.86%
FCF Margin	36.35%

Dividends & Yields

This stock pays an annual dividend of 0.82, which amounts to a dividend yield of 0.13%.

Dividend Per Share	0.82
Dividend Yield	0.13%
Dividend Growth (YoY)	81.76%
Years of Dividend Growth	1
Payout Ratio	68.81%
Buyback Yield	-0.07%
Shareholder Yield	0.06%
Earnings Yield	2.51%
FCF Yield	2.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ChemoMetec has an Altman Z-Score of 49.32 and a Piotroski F-Score of 6.

Altman Z-Score	49.32
Piotroski F-Score	6